Juan Portela Arraiza, MD
Otolaryngology · Manati, PRNPI 1063461788
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Sanofi at 48.8% of the total. Reporting peaked in 2019 at $4,647 and has fallen 91.8% since, to $382 in 2025. Among otolaryngology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $90.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- Intersect ENT, Inc.$2K
- Medtronic$169
- AstraZeneca$108
- Edwards Lifesciences$103
- Stryker$99
- plus $233 from 4 others
What the payments were for
- Consulting fees$1,65028%
- Travel & lodging$1,66928%
- Food & beverage$2,53943%
- Education$341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 37 | $2,876 |
| Intersect ENT, Inc. | 8 | $2,305 |
| Medtronic | 4 | $169 |
| AstraZeneca | 1 | $108 |
| Edwards Lifesciences | 1 | $103 |
| Stryker | 4 | $99 |
| Sanofi-aventis U.S. LLC | 4 | $91 |
| GSK | 4 | $87 |
| Amgen | 1 | $34 |
| Johnson & Johnson | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$2,331
- PROPEL$2,180
- SINUVA$2,039
- DERMATITIS - DISEASE$120
- ASTHMA - DISEASE$120
- NASAL POLYPOSIS - DISEASE$120
- TEZSPIRE$108
- ClearSight System$103
How this compares
$5,893 in reported general payments places this provider in the 95th percentile of 55 otolaryngology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 46 | $258,648 |
| Azelastine Hcl | 657 | $13,364 |
| Fluticasone Propionate | 869 | $12,631 |
| Ipratropium Bromide | 143 | $5,066 |
| Fluocinolone Acetonide Oil | 52 | $3,858 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 32 | $3,116 |
| Mometasone Furoate | 18 | $1,244 |
| Famotidine | 195 | $1,019 |
| Pantoprazole Sodium | 120 | $838 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $819 |
| SynthroidLevothyroxine Sodium | 11 | $729 |
| Montelukast Sodium | 76 | $617 |
| Doxycycline Hyclate | 62 | $588 |
| Methylprednisolone | 61 | $519 |
| Betamethasone Valerate | 32 | $444 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Manati
- Yadiel AlamedaManati$393
- Luis TarratsCayey$23K
- Jose BusquetsSan Juan$3K
- Mario Corona RuizPonce$3K
- Bianca Rullan OliverSan Juan$3K
- Gabriel Rivera-RiveraArecibo$3K
- Miguel Garraton MartinSan Juan$2K
- Charles Juarbe SantosBayamon$2K
- Laureano Giraldez RodriguezGuaynabo$2K
- Jeamarie Pascual MarreroSan Juan$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.